0001959861-23-000001.txt : 20230105 0001959861-23-000001.hdr.sgml : 20230105 20230105124912 ACCESSION NUMBER: 0001959861-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 EFFECTIVENESS DATE: 20230105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Urica Therapeutics, Inc. CENTRAL INDEX KEY: 0001959861 IRS NUMBER: 823474871 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-469777 FILM NUMBER: 23510379 BUSINESS ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 D 1 primary_doc.xml X0708 D LIVE 0001959861 Urica Therapeutics, Inc. 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL FLORIDA 33154 781-652-4500 DELAWARE None None Corporation true Jay D Kranzler, M.D., Ph.D. c/o Urica Therapeutics, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands FL FLORIDA 33154 Executive Officer Director Lindsay A. Rosenwald, M.D. c/o Urica Therapeutics, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands FL FLORIDA 33154 Director Michael S. Weiss c/o Urica Therapeutics, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands FL FLORIDA 33154 Director Vibeke S. Strand, M.D. c/o Urica Therapeutics, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands FL FLORIDA 33154 Director Raymond S. Zheng c/o Urica Therapeutics, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands FL FLORIDA 33154 Executive Officer Director Biotechnology Decline to Disclose 06b false 2022-12-27 false true false 0 Harley Capital LLC 310046 Harley Capital LLC 310046 55 Post Road West 3rd Floor Westport CT CONNECTICUT 06880 All States false 5000000 2533350 2466650 The maximum offering amount may be increased by up to an additional $750,000. false 26 253335 0 As Placement Agent, Harley Capital LLC also received warrants to purchase an amount of securities equal to 10% of the securities sold in this offering. 0 false Urica Therapeutics, Inc. /s/ David Jin David Jin Treasurer 2023-01-05